Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis
Status unconfirmed · Not applicable
Conditions studied: End Stage Renal Failure on Dialysis
In brief
Hemodialysis keeps patients with renal failure alive but does not restore normal health. Retention of chemicals that bind to plasma proteins and are therefore poorly removed by dialysis may contribute to ill health in patients receiving conventional treatment. This proposal will test the effect of a new method designed to improve the removal of protein-bound solutes during dialysis. The effects on blood chemical levels of two different dialysis prescriptions will be tested in patients already undergoing nocturnal in-center hemodialysis three times weekly.
Key facts
- Study ID
- NCT01892839
- Run by
- Palo Alto Veterans Institute for Research
- People needed
- 24
- Starts
- 2013-07-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2015-07-13
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- stable on nocturnal in-center dialysis located close to Stanford University and VA Palo Alto
You may not qualify if…
- recent use of antibiotics
- gastrointestinal disease
Where it is running
- Satellite Redwood City — Redwood City, California, United States (enrolling)
- Stanford University — Stanford, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.